Advanced search
Publication Cover
Therapeutics and Clinical Risk Management Volume 14, 2018 - Issue
Submit an article Journal homepage
435
Views
49
CrossRef citations to date
0
Altmetric
Review

Emerging treatment options for the management of pemphigus vulgaris

Khalaf KridinDepartment of Dermatology, Rambam Health Care Campus, Haifa, IsraelCorrespondence[email protected]
Pages 757-778 | Published online: 27 Apr 2018

Citations (49)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Khalaf Kridin & A. Razzaque Ahmed. (2021) The evolving role of rituximab in the treatment of pemphigus vulgaris: a comprehensive state-of-the-art review. Expert Opinion on Biological Therapy 21:4, pages 443-454.
Read now
Ayman Grada, Zaidal Obagi & Tania Phillips. (2019) Management of chronic wounds in patients with pemphigus. Chronic Wound Care Management and Research 6, pages 89-98.
Read now
A. Bilgic & D. F. Murrell. (2019) What is novel in the clinical management of pemphigus. Expert Review of Clinical Pharmacology 12:10, pages 973-980.
Read now
Rebecca L. Yanovsky, Michael McLeod & A.Razzaque Ahmed. (2019) Treatment of pemphigus vulgaris: part 2 – emerging therapies. Expert Review of Clinical Immunology 15:10, pages 1061-1071.
Read now
Rebecca L. Yanovsky, Michael McLeod & A. Razzaque Ahmed. (2019) Treatment of pemphigus vulgaris: part 1 – current therapies. Expert Review of Clinical Immunology 15:10, pages 1047-1060.
Read now

Articles from other publishers (44)

Emily Eachus, Lauren E DeLamielleure, Samrah Mitha, Taha F Rasul & Arfa Faiz. (2023) Scalp, Oral, and Nail Pemphigus Vulgaris: Clinical Characteristics and a Review of the Literature. Cureus.
Crossref
Yazan Hassona, Dana Altoum, Dua'a Alqaisi, Dina Taimeh & Faleh Sawair. (2023) Management of auto‐immune blistering disease in an older patient with severe intellectual disability. Special Care in Dentistry.
Crossref
Ali Al Bshabshe, Wesam F. Mousa & Nashwa Nor El-Dein. (2023) An Overview of Clinical Manifestations of Dermatological Disorders in Intensive Care Units: What Should Intensivists Be Aware of?. Diagnostics 13:7, pages 1290.
Crossref
Yangai Liu & Fei Wang. (2022) Failure of double filtration plasmapheresis to treat severe pemphigus vulgaris: A case report. Journal of Clinical Apheresis.
Crossref
Wafaa Mohamed Abd El‐Magid, Sheren FM Ahmed, Hanan Assaf, Reham Ebraheem Abd Elkhalek & Marwa Mohamed. (2022) Immunohistochemical expression of regulatory T cells (CD 4 + CD 25 + bright FOXP 3 + ) in pemphigus patients . Journal of Cosmetic Dermatology 21:10, pages 4871-4876.
Crossref
Raushan Kumar Chaudhary, Ramesh Bhandari, Bhavana Doshi, Satish S Karoli, Sowmya Spoorthi Marripalli & MS Ganachari. (2022) Gefitinib induced Pemphigus Vulgaris with PRIDE complex. Journal of Oncology Pharmacy Practice 28:6, pages 1465-1473.
Crossref
Rajesh Kumar Muniandy, Nagarajan Nagalingam, Sat Lin Liew & Sook Yee Michelle Voo. (2022) Pain management of pemphigus vulgaris. BMJ Case Reports 15:9, pages e250803.
Crossref
Ana Maria Sciuca, Mihaela Paula Toader, Carmen Gabriela Stelea, George Alexandru Maftei, Oana Elena Ciurcanu, Ovidiu Mihail Stefanescu, Bianca-Andreea Onofrei & Cristina Popa. (2022) Desquamative Gingivitis in the Context of Autoimmune Bullous Dermatoses and Lichen Planus—Challenges in the Diagnosis and Treatment. Diagnostics 12:7, pages 1754.
Crossref
Xueyi Huang, Xiaoqian Liang, Jiao Zhang, Hang Su & Yongfeng Chen. (2022) Pemphigus during the COVID-19 Epidemic: Infection Risk, Vaccine Responses and Management Strategies. Journal of Clinical Medicine 11:14, pages 3968.
Crossref
Uğur Hacı Musabak, Tuba Erdoğan & Mustafa Tunca. (2022) Pemphigus vulgaris in a patient with primary hypogammaglobulinemia: A case report. TURKDERM 56:2, pages 80-83.
Crossref
Elisabet Nylander. 2022. Ridley's The Vulva. Ridley's The Vulva 180 185 .
Huijie Yuan, Meng Pan, Hongxiang Chen & Xuming Mao. (2022) Immunotherapy for Pemphigus: Present and Future. Frontiers in Medicine 9.
Crossref
Nikoo Mozafari, Raziyeh Ganji & Parviz Toossi. (2022) A rare new presentation of pemphigus vulgaris. Clinical Case Reports 10:6.
Crossref
Erin Somerville, Kurt Gebauer & Andrew Mclean‐Tooke. (2022) Treatment of pemphigus in Australia: Aligning current practises with global recommendations. Australasian Journal of Dermatology 63:2, pages 190-196.
Crossref
Yanina Kutasevych, Aliya Abdalla, Iryna Oliinyk, Iryna Mashtakova & Yuliia Shcherbakova. (2022) RETROSPECTIVE CHART ANALYSIS OF PATIENTS DIGNOSED WITH ACANTHOLYTIC PEMPHIGUS FOR THE PERIOD 2008-2018. Wiadomości Lekarskie 75:2, pages 416-421.
Crossref
Shiti Bose & Bhushan Madke. (2022) A comprehensive review of immunosuppressive drugs in pediatric dermatoses: Part I - Corticosteroids, azathioprine, and cyclosporine-A. Indian Journal of Paediatric Dermatology 23:3, pages 191.
Crossref
VikramK Mahajan, KaraninderS Mehta, Jyotshna Sharma, Prabal Kumar, PushpinderS Chauhan, Ravinder Singh, Sujaya Manvi, Sanket Vashist, Anuj Sharma & AnjuL Sharma. (2022) The demographic attributes, clinical features, and optimal management of 143 patients with pemphigus: A retrospective observational study from a tertiary care center of India. Indian Dermatology Online Journal 13:2, pages 207.
Crossref
Nika Kianfar, Shayan Dasdar, Hamidreza Mahmoudi & Maryam Daneshpazhooh. (2022) Burden of pemphigus vulgaris with a particular focus on women: A review. International Journal of Women’s Dermatology 8:3, pages e056.
Crossref
Martin Röcken, Beatrix Evers & Tilo Biedermann. 2022. Braun-Falco´s Dermatology. Braun-Falco´s Dermatology 23 34 .
Diana Kneiber, Eric H. Kowalski & Kyle T. Amber. 2022. The Immunogenetics of Dermatologic Diseases. The Immunogenetics of Dermatologic Diseases 173 212 .
Wenzhe Zhao, Jingying Wang, Haiqin Zhu & Meng Pan. (2021) Comparison of Guidelines for Management of Pemphigus: a Review of Systemic Corticosteroids, Rituximab, and Other Immunosuppressive Therapies. Clinical Reviews in Allergy & Immunology 61:3, pages 351-362.
Crossref
Eya Moussaoui, Yassine Oueslati, Lamia Oualha, Mohamed Denguezli, Badreddine Sriha & Nabiha Douki. (2021) Simultaneous Oral and Umbilical Locations as a First Sign of Pemphigus Vulgaris. Case Reports in Dentistry 2021, pages 1-7.
Crossref
Federico Bardazzi, Camilla Loi, Adriano Chessa Marco, Ambra Di Altobrando, Federica Filippi, Rossella Lacava, Filippo Viviani, Riccardo Balestri, Miriam Leuzzi & Lidia Sacchelli. (2021) Therapeutic approaches and targets for treatment of autoimmune bullous diseases. Dermatologic Therapy 34:5.
Crossref
Anuradha Bishnoi, Dipankar De, Sanjeev Handa & Rahul Mahajan. (2021) Biologics in autoimmune bullous diseases: Current scenario. Indian Journal of Dermatology, Venereology and Leprology 87, pages 611-620.
Crossref
Kriti Sareen, Fozia Sultana, Zabin Mirza, Kalpna Thakur, Ekta Parmar & Prachi Patekar. (2021) Management of Pemphigus Vulgaris Using Dexamethasone Cyclophosphamide Pulse Therapy: A Case Report. Journal of Research and Advancement in Dentistry 12:5, pages 275-277.
Crossref
S A JarAllah & Z S Al-Garawi. (2021) A review on autoimmune diseases Myasthenia Gravis: Causes, pathogenesis, symptoms and treatment. Journal of Physics: Conference Series 1853:1, pages 012063.
Crossref
Dilek Yiğit, İlknur Balta, Hasan Yiğit & Hatice Meral Ekşioğlu. (2020) Nocardiosis in a patient with pemphigus foliaceus treated with rituximab. Dermatologic Therapy 34:1.
Crossref
Xiaowei Jin, Jordan Rosenbohm, Eunju Kim, Amir Monemian Esfahani, Kristina Seiffert‐Sinha, James K. WahlIIIIII, Jung Yul Lim, Animesh A. Sinha & Ruiguo Yang. (2021) Modulation of Mechanical Stress Mitigates Anti‐Dsg3 Antibody‐Induced Dissociation of Cell–Cell Adhesion. Advanced Biology 5:1, pages 2000159.
Crossref
Khalaf Kridin, Virginia A. Jones, Payal M. Patel, Shira Zelber-Sagi, Christoph M. Hammers, Giovanni Damiani, Kyle T. Amber & Arnon D. Cohen. (2020) Patients with pemphigus are at an increased risk of developing rheumatoid arthritis: a large-scale cohort study. Immunologic Research 68:6, pages 373-378.
Crossref
Roberta Scarpone, Wojciech Francuzik, Margitta Worm & Guido Heine. (2020) Therapy Changes During Pemphigus Management: A Retrospective Analysis. Frontiers in Medicine 7.
Crossref
Farnaz Sepandar, Maryam Daneshpazhooh, Mahmoud Djalali, Hamed Mohammadi, Elham Yaghubi, Zahra Fakhri, Hajar Tavakoli, Ehsan Ghaedi, Ali Keshavarz, Mahnaz Zarei, Mohammad Amin Shahrbaf, Narges Ghandi, Mina Darand & Mohamad Hassan Javanbakht. (2019) The effect of l ‐carnitine supplementation on serum levels of omentin‐1, visfatin and SFRP5 and glycemic indices in patients with pemphigus vulgaris: A randomized, double‐blind, placebo‐controlled clinical trial . Phytotherapy Research 34:4, pages 859-866.
Crossref
Khalaf Kridin & A. Razzaque Ahmed. (2020) Post-rituximab immunoglobulin M (IgM) hypogammaglobulinemia. Autoimmunity Reviews 19:3, pages 102466.
Crossref
M. Barroil, C. Girard, M. Lerisson, V. Negroni, A.-S. Bertrand, V. Pallure, D. Bessis, B. Guillot & O. Dereure. (2020) Utilisation en pratique du rituximab en 2nde ligne et au-delà dans le traitement du pemphigus: série rétrospective. Annales de Dermatologie et de Vénéréologie 147:3, pages 173-178.
Crossref
James E. Frampton. (2019) Rituximab: A Review in Pemphigus Vulgaris. American Journal of Clinical Dermatology 21:1, pages 149-156.
Crossref
Martin Röcken, Beatrix Evers & Tilo Biedermann. 2020. Braun-Falco´s Dermatology. Braun-Falco´s Dermatology 1 12 .
Reshmi Gangan. (2019) Refractory pemphigus vulgaris: Treatment options. Journal of Skin and Sexually Transmitted Diseases 1, pages 61-65.
Crossref
K. Kridin, E.H. Kowalski, D. Kneiber, R. Laufer‐Britva & K.T. Amber. (2019) From bench to bedside: evolving therapeutic targets in autoimmune blistering disease. Journal of the European Academy of Dermatology and Venereology 33:12, pages 2239-2252.
Crossref
Aheen Faisal Mohamad, Lars Iversen & Rikke Bech. (2019) Pemphigus Vulgaris: Short Time to Relapse in Patients Treated in a Danish Tertiary Referral Center. Frontiers in Medicine 6.
Crossref
Ioana Popescu, Laura Statescu, Dan Vata, Elena Andrese, Adriana Patrascu, Ioana-Alina Grajdeanu & Laura Solovastru. (2019) Pemphigus vulgaris - approach and management (Review). Experimental and Therapeutic Medicine.
Crossref
Dario Didona, Roberto Maglie, Rüdiger Eming & Michael Hertl. (2019) Pemphigus: Current and Future Therapeutic Strategies. Frontiers in Immunology 10.
Crossref
Asli Bilgic Temel & Dedee F Murrell. (2019) Pharmacological advances in pemphigus. Current Opinion in Pharmacology 46, pages 44-49.
Crossref
Natalie E. Stevens, Allison J. Cowin & Zlatko Kopecki. (2019) Skin Barrier and Autoimmunity—Mechanisms and Novel Therapeutic Approaches for Autoimmune Blistering Diseases of the Skin. Frontiers in Immunology 10.
Crossref
Khalaf Kridin, Christine Ahn, William C. Huang, Ahmed Ansari & Naveed Sami. (2019) Treatment Update of Autoimmune Blistering Diseases. Dermatologic Clinics 37:2, pages 215-228.
Crossref
N. van Beek, D. Zillikens & E. Schmidt. (2019) Aktuelle Therapie des PemphigusTherapy of pemphigus. Der Hautarzt.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.